Prof Katie Louise Flanagan

Infectious Diseases Specialist and Clinical Professor, University of Tasmania
Professor Flanagan is a clinician scientist with more than 20 years’ experience in clinical infectious diseases and an international reputation in vaccine and pathogen immunology. She has led numerous vaccine immunology trials throughout the world including trials of novel malaria and HIV vaccines in Africa, and trials of the immunological effects of commonly used vaccines in the young and elderly. Her current research involves applying systems biology techniques (e.g., transcriptomics, epigenetics, metabolomics) to study human responses to vaccination, particularly at the extremes of age; and the role of biological sex in vaccine-specific responses.

More from this expert

Australia is now into its next COVID wave. But it has taken several months for a consistent pattern to emerge across Australia.

Clinical Articles iconClinical Articles